InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
4,274.51
(
0.02%
)
US TECH 100
14,232.00
(
0.45%
)
Dow Jones
33,550.27
(
-0.20%
)
Brent Oil
94.31
(
1.85%
)
Bitcoin
26,265.00
(
0.22%
)
Post# of 3188
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

gi197845

Send PM Follow Ignore
Followers 5
Posts 2466
Boards Moderated 0
Alias Born 08/16/2016

gi197845

Re: None

Wednesday, 07/13/2022 11:54:43 AM

Wednesday, July 13, 2022 11:54:43 AM

Post# of 3188
Jefferies Financial Group cut shares of ACADIA Pharmaceuticals from a "buy" rating to an "underperform" rating and decreased their price objective for the company from $25.00 to $10.00 in a report on Tuesday, June 21st.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent ACAD News
More ACAD News
InvestorsHub NewsWire

FEATURED SciSparc Announces Expected Implementation of 1-for-26 Reverse Share Split • Sep 27, 2023 9:49 AM

FEATURED 1606 Corp. Partners with Cool Blue To Launch ChatCBD, a New AI Customer Experience • Sep 26, 2023 8:37 AM

Branded Legacy Inc. Invests Heavily in Innovation and Growth with $540,000 Expansion • BLEG • Sep 26, 2023 10:37 AM

Avant Technologies Reshaping Future of Supercomputing and AI with Disruptive Private Cloud Infrastructure • AVAI • Sep 26, 2023 8:45 AM

Image Protect Announces Debt Forgiveness in Excess of $1,400,000 Clearing the Path for Pending New Business Development • IMTL • Sep 26, 2023 8:16 AM

CGrowth Capital Inc. Nears Key Milestone in Lithium Mining Expansion • CGRA • Sep 26, 2023 8:08 AM

Start posting your company's news
Only $200 per official company press release!